Mach7 Technologies Limited (ASX:M7T)
0.2900
-0.0100 (-3.33%)
Nov 3, 2025, 2:38 PM AEST
Mach7 Technologies Revenue
In the fiscal year ending June 30, 2025, Mach7 Technologies had annual revenue of 33.79M AUD with 16.00% growth. Mach7 Technologies had revenue of 16.05M in the half year ending June 30, 2025, with 17.56% growth.
Revenue
33.79M
Revenue Growth
+16.00%
P/S Ratio
2.09
Revenue / Employee
n/a
Employees
58
Market Cap
70.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 33.79M | 4.66M | 16.00% |
| Jun 30, 2024 | 29.13M | -937.12K | -3.12% |
| Jun 30, 2023 | 30.06M | 3.67M | 13.92% |
| Jun 30, 2022 | 26.39M | 7.35M | 38.57% |
| Jun 30, 2021 | 19.04M | 97.00K | 0.51% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |
Mach7 Technologies News
- 3 days ago - Mach7 Technologies Limited (TDMMF) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Mach7 Technologies Limited 2026 Q1 - Results - Earnings Call Presentation - Seeking Alpha